CorriXR Therapeutics, an oncology-focused biotherapeutics company pioneering a ground-breaking gene editing platform technology, InhaTarget Therapeutics, a company dedicated to the early development ...
2 天on MSN
Sneaky senescent cells that resist cancer treatment can provide druggable lung cancer target
Senescent fibroblasts are aging cells that no longer divide and protect against tumor development. Yet two decades have gone ...
For decades, lung cancer has been associated with stigma, anxiety, and loss. Advances in screening, therapeutics, and ...
Expanded lung cancer screening and smoking cessation programs could prevent tens of thousands of deaths, but systemic barriers and outdated criteria leave high-risk communities behind.
Pulmonary metastasectomy for colorectal cancer is a commonly performed and well-established practice of ∼50 years standing. However, there have been no controlled studies, randomised or otherwise. We ...
Given that many tiny nodules were found, these are unlikely to be lung cancer, which is generally only a single nodule ...
Two teams discover how small cell lung cancer hijacks neural pathways to proliferate faster, especially to the brain. Common ...
Can you get lung cancer without smoking? Yes. A leading oncologist explains the key differences in diagnosis, treatment, and ...
L&T Technology Services has announced the development of a next-generation AI-powered platform for respiratory diagnostics and lung navigation. It will be debuted at RSNA 2025.
EMERGE: A Randomized Phase II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Advanced Glycoprotein NMB–Expressing Breast Cancer This study was undertaken to determine the magnitude of ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈